Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
17.6% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
20
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.1% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
17
users have liked this narrative
7
users have commented on this narrative
24
users have followed this narrative
9 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
4.7% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
45.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Curis
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Clinical Advances Will Expand Hematologic Cancer Market Opportunities
Key Takeaways Advancing a key therapy in multiple cancer types and expanding its use could unlock major new markets and drive long-term revenue growth. Strategic cost controls and externally funded trials are minimizing cash burn while maximizing pipeline value and supporting future profitability.
View narrative
US$16.33
FV
90.5% undervalued
intrinsic discount
45.17%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
7 days ago
author updated this narrative
Cambium Networks
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
CN Wave 60 And PMP Platform Will Optimize Operations
Key Takeaways New product launches and sector expansion signal potential revenue growth and adoption in industrial and retail markets. Supply chain improvements and product line convergence indicate enhanced net margins and improved earnings through increased operational efficiencies.
View narrative
US$7.00
FV
90.3% undervalued
intrinsic discount
15.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
7 days ago
author updated this narrative
CXApp
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Fortune 1000 Demand And Agentic AI Will Expand Global Opportunities
Key Takeaways Global expansion among major clients and strong adoption of key platform modules support robust recurring revenue growth and improving profitability through high-margin software. Accelerated AI innovation and strategic partnerships drive differentiation, enabling market share gains and high-margin upselling of analytics and digital workplace tools.
View narrative
US$3.00
FV
74.9% undervalued
intrinsic discount
26.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
7 days ago
author updated this narrative
Lisata Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Positive Clinical Trials Will Expand Precision Oncology Markets
Key Takeaways Strong clinical progress, strategic partnerships, and robust patent protection position Lisata for future growth and competitive advantage in oncology therapeutics. Prudent cost management and near-term non-dilutive funding enhance financial sustainability and support ongoing development and commercialization efforts.
View narrative
US$20.67
FV
88.4% undervalued
intrinsic discount
78.58%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
7 days ago
author updated this narrative
KORE Group Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
IoT And 5G Will Expand Future Market Opportunity
Key Takeaways Growing IoT adoption and digital transformation in regulated sectors are expanding recurring, higher-margin revenue streams and supporting stable, long-term topline growth. Innovation in network technologies and platform offerings is driving operational efficiency, customer retention, and financial flexibility for sustained profitability and future expansion.
View narrative
US$6.00
FV
64.2% undervalued
intrinsic discount
5.91%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
7 days ago
author updated this narrative
Farmer Bros
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
DSD Optimization And Eurest Partnership Will Advance Operations
Key Takeaways Enhancing DSD and strategic leadership additions aim to boost revenue, customer growth, and retention. Product diversification and proactive market strategies are set to improve gross margins and earnings stability.
View narrative
US$3.75
FV
53.6% undervalued
intrinsic discount
3.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
7 days ago
author updated this narrative
WidePoint
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Federal Contracts And Cloud Demand Will Unlock Future Potential
Key Takeaways High likelihood of major contract wins and regulatory shifts are set to boost recurring revenue, margin expansion, and long-term growth. Strategic diversification and partnerships are reducing concentration risk while expanding mobile identity management across new sectors and markets.
View narrative
US$7.50
FV
47.3% undervalued
intrinsic discount
13.08%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
3
users have followed this narrative
7 days ago
author updated this narrative
Movano
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
FDA Clearance And Partnerships Will Expand Wearable Healthcare Reach
Key Takeaways Successful sales and market penetration of the Evie Rings indicate future revenue growth, aided by an efficient customer acquisition strategy. Strategic alliances in the healthcare sector and innovative product development suggest strong future revenue streams and market diversification.
View narrative
US$30.00
FV
98.0% undervalued
intrinsic discount
288.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
7 days ago
author updated this narrative
Zedge
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
TikTok Return And Gen AI Will Unlock Monetization Opportunities
Key Takeaways Restructuring and workforce reduction aim to improve profitability while enhancing monetization channels to boost revenue. Deployment of AI capabilities and subscription growth suggest potential for sustained revenue growth and user engagement.
View narrative
US$5.00
FV
39.4% undervalued
intrinsic discount
1.87%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
7 days ago
author updated this narrative
Value any company in seconds
Popular companies